glp 1 sri lanka Arrival of GLP-1 weight-loss pill new headache for food makers Glp-1 Analogues Market Size, Share
Description
A further study presented at Digestive Disease Week 2025 of 993 patients found GLP-1RA to be associated with a statistically significant increase in clinical remission rates (HBI or Mayo score) at 3 months numerical at 6 and 12 months without an increase in side-effects

Lower risk of type 2 diabetes progression and cardiovascular disease

Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder

Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)

doi: 10.1007/s00125-023-05929-0

How are GLP-1 medications currently given in the UK
